Vardenafil is a phosphodiesterase type 5 (PDE5) inhibitor used for the treatment of erectile dysfunction (ED) in men. It works by inhibiting the breakdown of cyclic guanosine monophosphate (cGMP) in the corpus cavernosum, thereby enhancing nitric oxide–mediated smooth muscle relaxation and increasing blood flow to the penis during sexual stimulation.
It is available as oral tablets and orodispersible formulations.
Indications include:
∙ Erectile dysfunction (impotence)
∙ Investigational use in pulmonary arterial hypertension (not widely approved for this indication)
Parent: Vardenafil
Parent: Vardenafil
Parent: Vardenafil Hydrochloride Trihydrate
Parent: Vardenafil
Parent: Vardenafil
Parent: Vardenafil
Impurities in vardenafil arise from its multi-step chemical synthesis, which involves pyrimidinone and piperazine ring construction, sulfonation, and selective alkylation, as well as from degradation under light, heat, and oxidative stress. As an orally administered drug for chronic or situational use, its impurities must be controlled under ICH Q3A/B, USP, and EP guidelines.
Process-Related Impurities
Degradation Impurities
Elemental Impurities
Analytical Techniques for Impurity Detection
Vardenafil is used to treat erectile dysfunction by enhancing blood flow to the penis in response to sexual stimulation.
It inhibits PDE5, which increases cGMP levels in the corpus cavernosum, promoting smooth muscle relaxation and erection during sexual arousal.
Yes, but high-fat meals may delay its onset of action. Alcohol should be limited to avoid enhanced side effects like low blood pressure or dizziness.
Vardenafil is generally stable but should be protected from moisture, heat, and light. It should be stored at room temperature in its original packaging.
